Close Menu

NEW YORK (GenomeWeb) – Invitae said after the close of the market on Monday that it plans to offer $50 million in shares of its common stock in a public offering.

Based on a stock price of $7.02 per share, the last reported sale price of its stock on March 23, Invitae said in a prospectus filed with the US Securities and Exchange Commission that it anticipates offering 7,122,507 shares. The company also plans to give underwriters a 30-day option to purchase up to an additional $7.5 million of shares of its common stock at the public offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.